Skip to content

PHARE CHU: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PHARE CHU

BE 0454.360.965
NACE 86.220, Specialist medical practice
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€4,667
2024 · -€17,871+€13,204
Equity
€7,009
2024 · €11,676-€4,667
Cash
€7,628
2024 · €11,896-€4,267
Balance sheet total
€7,628
2024 · €11,896-€4,267

Largest movements

2024 to 2025
Assets
  • Cash -€4,267

    down €4,267 (-35.9%), from €11,896 to €7,628

    mainly Net result for the year (-€4,667)

Equity and liabilities
  • Profit (loss) carried forward -€4,667

    down €4,667 (-55.1%), from -€8,466 to -€13,133

  • Accrued charges and deferred income +€400

    new in 2025: €400

Income statement
  • Gross operating margin -€13,761

    down €13,761, from €9,973 to -€3,788

  • Other operating charges -€208

    down €208 (-34.2%), from €607 to €400

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€17,871
Gross operating margin -€13,761
Other operating charges +€208
Other operating items +€26,718
Financial charges +€40
Result 2025 -€4,667
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€4,267
Investment €0
Financing €0
Cash 2024 €11,896
Net result for the year -€4,667
Accrued charges and deferred income +€400
Cash 2025 €7,628
brings cash intakes cash out
Every line side by side 24 lines
Line Code 2024 2025 Change %
Total assets 20/58 €11,896 €7,628 -€4,267 -35.9%
Current assets 29/58 €11,896 €7,628 -€4,267 -35.9%
Cash at bank and in hand 54/58 €11,896 €7,628 -€4,267 -35.9%
Total equity and liabilities 10/49 €11,896 €7,628 -€4,267 -35.9%
Equity 10/15 €11,676 €7,009 -€4,667 -40.0%
Contributions 10/11 €18,035 €18,035 = 0.0%
Reserves 13 €2,107 €2,107 = 0.0%
Non-distributable reserves 130/1 €2,107 €2,107 = 0.0%
Reserves not available under the articles 1311 €2,107 €2,107 = 0.0%
Profit (loss) carried forward 14 -€8,466 -€13,133 -€4,667 -55.1%
Amounts payable 17/49 €220 €620 +€400 +182%
Amounts payable within one year 42/48 €220 €220 = 0.0%
Trade debts 44 €220 €220 = 0.0%
Suppliers 440/4 €220 €220 = 0.0%
Accrued charges and deferred income 492/3 - €400 +€400
Other operating charges 640/8 €607 €400 -€208 -34.2%
Non-recurring operating charges 66A €26,718 - -€26,718
Gross operating margin 9900 €9,973 -€3,788 -€13,761
Operating profit (loss) 9901 -€17,352 -€4,188 +€13,165 +75.9%
Financial charges 65/66B €519 €479 -€40 -7.7%
Recurring financial charges 65 €519 €479 -€40 -7.7%
Profit (loss) for the period before taxes 9903 -€17,871 -€4,667 +€13,204 +73.9%
Profit (loss) for the period 9904 -€17,871 -€4,667 +€13,204 +73.9%
Profit (loss) for the period to be appropriated 9905 -€17,871 -€4,667 +€13,204 +73.9%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 October 2026 via checked.be.